Lymphatic endothelial senescence is associated with drainage failure despite vessel expansion in pulmonary fibrosis
Authors:
- 1 November 2026
- journal article
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 331 (5) , C1274-C1296
Abstract
The lymphatic vasculature in fibrotic lungs expands morphologically yet fails functionally, revealing a fundamental dissociation between vessel density and drainage competence. Senescence-associated transcriptional reprogramming in lymphatic endothelial cells coincides with this transport failure and with suppression of key molecular signals governing macrophage egress, linking lymphatic dysfunction to sustained immune cell retention. Bidirectional lymphatic modulation in complementary fibrosis models identifies drainage competence as a decisive factor in disease outcome and a tractable therapeutic target.Keywords
Funding Information
- National Natural Science Foundation of China (82470105)
- National Natural Science Foundation of China (82090013)
- National Natural Science Foundation of China (82241011)
- Natural Science Foundation of Beijing Municipality (7242010)
- Beijing Nova Program (20240484639)
- Capital Medical University (CMU-CGT26C01)
- Open Fund of the Beijing Key Laboratory of Organ Synergy and Intelligent Regenerative Manufacturing (2026KFQG03)
- Chinese Institutes for Medical Research, Beijing (CX25XT03)
This publication has 77 references indexed in Scilit:
- Pulmonary fibrosis: pathogenesis and therapeutic strategiesMedcomm, 2024
- The Lymphatic Highway: How Lymphatics Drive Lung Health and DiseaseLung, 2024
- Disruption of extracellular redox balance drives persistent lung fibrosis and impairs fibrosis resolutionBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2023
- The Future of Clinical Trials in Idiopathic Pulmonary FibrosisJAMA, 2023
- The regulatory effect of pulmonary lymphatic drainage on silicosis fibrosisEcotoxicology and Environmental Safety, 2022
- Stimulation of the atypical chemokine receptor 3 (ACKR3) by a small-molecule agonist attenuates fibrosis in a preclinical liver but not lung injury modelCellular and Molecular Life Sciences, 2022
- Lymphatic Proliferation Ameliorates Pulmonary Fibrosis after Lung InjuryThe American Journal of Pathology, 2020
- The Lymphatic Vasculature in the 21st Century: Novel Functional Roles in Homeostasis and DiseaseCell, 2020
- Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot studyEBioMedicine, 2019
- Lymphatic Vessel Network Structure and Physiology2018